-

Northwell Health Pediatric Rheumatologist Recognized for Lifetime Achievement by the American College of Rheumatology

Barbara Anne Eberhard, MD, was named a master recipient of the award for her work and research in pediatric rheumatology.

MANHASSET, N.Y.--(BUSINESS WIRE)--For her dedication to research and leadership in rheumatology, Northwell Health’s Cohen Children’s Medical Center (CCMC) pediatric rheumatologist and Feinstein Institutes for Medical Research scientist Barbara Anne Eberhard, MD, has been awarded top honors by the American College of Rheumatology (ACR) and the Association of Rheumatology Professionals (ARP). Dr. Eberhard was recognized, and named an “ACR Master,” during the ACR Convergence 2023 annual conference which is being held November 10-15 in San Diego, California.

The ACR Master recognition is awarded to physician-researchers who have made significant contributions to the field of rheumatology. Dr. Eberhard spent her two-decade-long career working clinically and as a teacher in pediatric rheumatology in the Department of Pediatrics at CCMC, while also taking on research roles at CCMC and at the Feinstein Institutes. Her focus is on the care of children living with rheumatologic conditions including arthritis, vasculitis, dermatomyositis and systemic lupus erythematosus.

“Children who are living with rheumatologic conditions need special care and people to advocate for research into new therapies that could lead them to live happier, healthier lives,” said Dr. Eberhard. “I am honored to be recognized by the ACR and hope to inspire others to continue the care and advance clinical trials and studies that may benefit our patients.”

Dr. Eberhard also leads the Pediatric Lupus Clinic at Northwell Health, caring for more than 200 patients with pediatric lupus. She was previously past chair of the lupus subcommittee in the Child, Arthritis and Rheumatology Research Alliance (CARRA) from 2008 through 2015. In that role, she helped establish one of the largest clinical databases of pediatric lupus in the world, which now consists of more than 900 patients. Through CARRA, Dr. Eberhard is active in defining consensus treatment guidelines for the use of biologics in other autoimmune diseases and has gathered data demonstrating improved patient outcomes. Her research has led to the publication of 70 papers and over 50 published abstracts. She has been a mentor to more than 20 clinical research fellows and junior faculty, and is a founding member of the ACR/CARRA Mentoring Interest Group (AMIGO) that matches young physician-researchers with mentors from external institutions based on their research and clinical interests.

“Dr. Eberhard is a leader in rheumatology clinical care and research,” said Charles Schleien, MD, MBA, senior vice president and chair of pediatric services at Northwell Health, and the Philip Lanzkowsky Chair and Professor of Pediatrics at the Zucker School of Medicine at Hofstra/Northwell. “This recognition will advance future research and promote collaboration among her peers and colleagues even more, which will in turn benefit patients, which is what this is all about.”

About the Feinstein Institutes
The Feinstein Institutes for Medical Research is the home of the research institutes of Northwell Health, the largest health care provider and private employer in New York State. Encompassing 50 research labs, 3,000 clinical research studies and 5,000 researchers and staff, the Feinstein Institutes raises the standard of medical innovation through its five institutes of behavioral science, bioelectronic medicine, cancer, health system science, and molecular medicine. We make breakthroughs in genetics, oncology, brain research, mental health, autoimmunity, and are the global scientific leader in bioelectronic medicine – a new field of science that has the potential to revolutionize medicine. For more information about how we produce knowledge to cure disease, visit http://feinstein.northwell.edu and follow us on LinkedIn.

Contacts

Julianne Mosher Allen
516-880-4824
jmosherallen@northwell.edu

The Feinstein Institutes for Medical Research


Release Versions

Contacts

Julianne Mosher Allen
516-880-4824
jmosherallen@northwell.edu

More News From The Feinstein Institutes for Medical Research

Feinstein Institutes Awarded $8.9M for Care Planning Program in Older Adults and Those With Dementia

MANHASSET, N.Y.--(BUSINESS WIRE)--Northwell Health’s Feinstein Institutes for Medical Research aims to transform advanced care planning for older adults and those with Alzheimer’s disease and related dementias. The Feinstein Institutes secured a multi-year $8.9 million grant from the National Institutes of Health’s (NIH) National Institute on Aging (NIA) and will collaborate with Tufts University and Dartmouth Health to conduct the Advancing Ethical Goals in Society (AEGIS) clinical trial. This...

Cancer Cases Explode Among WTC Health Patients, Underscores Ongoing Crisis 25 Years After 9/11

NEW HYDE PARK, N.Y.--(BUSINESS WIRE)--Twenty-five years after the World Trade Center terror attack on September 11, 2001, physicians and patients gathered at Northwell’s Long Island Jewish (LIJ) Medical Center to commemorate the grim anniversary and to sound the alarm to an ongoing health crisis. The past is prologue for a slow-motion health disaster as cancer cases have exploded among some of the approximately 145,000 people currently enrolled in the World Trade Center (WTC) Health Program, wh...

Feinstein Institutes’ researchers find jumping genes at the center of blood immune networks disrupted in schizophrenia

MANHASSET, N.Y.--(BUSINESS WIRE)--Unlocking a crucial piece of schizophrenia’s molecular puzzle, scientists at Northwell Health’s Feinstein Institutes for Medical Research have found that jumping genes, also known as transposable elements, are linked to a communication breakdown in the blood gene expression networks of people living with schizophrenia. Jumping genes are DNA sequences from ancient viruses and other elements that could once move around the human genome – and in rare cases still c...
Back to Newsroom